TLR4 and cardiac hypertrophy: For instance, eritoran, a TLR4 antagonist, proved effective in a murine model of transverse aortic constriction-induced cardiac hypertrophy, showing the reduced production of pro-inflammatory cytokines (such as IL-1β and IL-6) and the increased production of anti-inflammatory cytokines (such as IL-10).